CRISM Therapeutics (CRTX) Competitors GBX 7 -1.00 (-12.50%) As of 02/21/2025 11:07 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitors CRTX vs. GLR, BRES, FRG, TGR, ARV, PXC, PREM, BMN, TUN, and BEMShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Galileo Resources (GLR), Blencowe Resources (BRES), Firering Strategic Minerals (FRG), Tirupati Graphite (TGR), Artemis Resources (ARV), Phoenix Copper (PXC), Premier African Minerals (PREM), Bushveld Minerals (BMN), Tungsten West (TUN), and Beowulf Mining (BEM). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. Galileo Resources Blencowe Resources Firering Strategic Minerals Tirupati Graphite Artemis Resources Phoenix Copper Premier African Minerals Bushveld Minerals Tungsten West Beowulf Mining CRISM Therapeutics (LON:CRTX) and Galileo Resources (LON:GLR) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Does the MarketBeat Community believe in CRTX or GLR? Galileo Resources received 85 more outperform votes than CRISM Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformCRISM TherapeuticsN/AN/AGalileo ResourcesOutperform Votes8559.86% Underperform Votes5740.14% Does the media prefer CRTX or GLR? In the previous week, Galileo Resources' average media sentiment score of 0.95 beat CRISM Therapeutics' score of 0.00 indicating that Galileo Resources is being referred to more favorably in the news media. Company Overall Sentiment CRISM Therapeutics Neutral Galileo Resources Positive Which has better valuation and earnings, CRTX or GLR? Galileo Resources is trading at a lower price-to-earnings ratio than CRISM Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCRISM TherapeuticsN/AN/A-£792.20K-£5.81-1.20Galileo ResourcesN/AN/A-£1.05M-£0.09-8.84 Which has more risk and volatility, CRTX or GLR? CRISM Therapeutics has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Galileo Resources has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Do insiders & institutionals have more ownership in CRTX or GLR? 8.9% of Galileo Resources shares are held by institutional investors. 68.8% of CRISM Therapeutics shares are held by insiders. Comparatively, 74.8% of Galileo Resources shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is CRTX or GLR more profitable? Galileo Resources' return on equity of -9.30% beat CRISM Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CRISM TherapeuticsN/A -13.12% -26.77% Galileo Resources N/A -9.30%-4.51% SummaryGalileo Resources beats CRISM Therapeutics on 8 of the 10 factors compared between the two stocks. Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£763,000.00£1.14B£3.15B£2.65BDividend YieldN/A6.24%5.14%4.99%P/E Ratio-1.2045.28104.61162.70Price / SalesN/A27,597.0825,801,666,827,886,400.00314,812.14Price / CashN/A25.2924.3528.17Price / Book0.166.104.935.17Net Income-£792,204.93£70.71M£152.67M£5.77B7 Day Performance-12.50%-0.49%-0.87%-0.99%1 Month Performance-18.60%3.32%2.23%-0.83%1 Year PerformanceN/A50.74%32.79%38.83% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 7-12.5%N/AN/A£763,000.00N/A-1.204Gap DownHigh Trading VolumeGLRGalileo ResourcesN/AGBX 0.81+1.6%N/A-36.0%£9.43MN/A-13.001News CoverageHigh Trading VolumeBRESBlencowe ResourcesN/AGBX 4.05-1.3%N/A-3.4%£9.16MN/A-404.503News CoveragePositive NewsFRGFirering Strategic MineralsN/AGBX 4.74+15.6%N/A+26.3%£8.73M£1.61M-158.00N/AGap UpHigh Trading VolumeTGRTirupati GraphiteN/AGBX 6.25flatN/AN/A£8.09M£4.96M104.1736,000ARVArtemis ResourcesN/AGBX 0.41-4.0%N/A-41.2%£7.83MN/A-40.80N/AGap UpPXCPhoenix CopperN/AGBX 4-5.9%N/A-68.9%£7.38MN/A-400.0018Gap UpPREMPremier African MineralsN/AGBX 0.02-4.5%N/A-91.7%£7.20M£2,000.002.2519BMNBushveld MineralsN/AN/AN/AN/A£7.07M£107.92M-5.10758TUNTungsten WestN/AGBX 3.42+3.5%N/A+128.3%£6.45M£1.14M-42.6915Gap UpBEMBeowulf MiningN/AGBX 16.58+3.6%N/A+1,322.7%£6.44M£173.31M-236.8613Gap UpHigh Trading Volume Related Companies and Tools Related Companies Galileo Resources Alternatives Blencowe Resources Alternatives Firering Strategic Minerals Alternatives Tirupati Graphite Alternatives Artemis Resources Alternatives Phoenix Copper Alternatives Premier African Minerals Alternatives Bushveld Minerals Alternatives Tungsten West Alternatives Beowulf Mining Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CRTX) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
